Buy Xigduo from Canada

$98.99$104.99

Xigduo acts synergistically through its components. Metformin reduces hepatic glucose production and improves insulin sensitivity, while dapagliflozin reduces renal glucose reabsorption, promoting glucose excretion via urine. This combined action helps lower blood sugar levels more effectively than either drug alone.

- +
Compare
SKU: N/A Category:

Description

Xigduo, a combination oral medication consisting of dapagliflozin and metformin, is utilized in the management of type 2 diabetes. This medication combines the actions of dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which helps the kidneys eliminate glucose from the bloodstream, with metformin, which decreases glucose production in the liver and improves the body’s response to insulin.